CVS Group plc (LON:CVSG – Get Free Report) crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 1,227.29 and traded as low as GBX 1,137. CVS Group shares last traded at GBX 1,140, with a volume of 493,341 shares traded.
Wall Street Analysts Forecast Growth
CVSG has been the topic of several analyst reports. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research report on Friday, September 25th. Finally, Shore Capital Group reissued a “hold” rating and set a GBX 1,400 target price on shares of CVS Group in a research report on Thursday, September 24th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Group has an average rating of “Moderate Buy” and an average price target of GBX 1,666.67.
Get Our Latest Report on CVS Group
CVS Group Trading Down 1.7%
CVS Group (LON:CVSG – Get Free Report) last announced its earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. Sell-side analysts predict that CVS Group plc will post 93.9393939 EPS for the current year.
Insider Transactions at CVS Group
In related news, insider Joanne Shaw acquired 1,592 shares of the stock in a transaction dated Monday, August 10th. The stock was acquired at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider David Wilton purchased 1,500 shares of the stock in a transaction on Tuesday, August 4th. The shares were purchased at an average cost of GBX 1,276 per share, with a total value of £19,140. Over the last ninety days, insiders purchased 3,860 shares of company stock worth $4,956,696. Company insiders own 1.48% of the company’s stock.
About CVS Group
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
See Also
- Five stocks we like better than CVS Group
- Liberty Energy’s AI Power Push Has Wall Street Divided
- Why Valley National Is Buying Growth Instead of Building It
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
